CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.000015 (8.11%)
At close: May 5, 2026
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $295.15 thousand as of May 5, 2026. Its market cap has decreased by -10.14% in one year.
Market Cap
295.15K
Enterprise Value
1.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 295.15K, an increase of 23.98%. That is a compound annual growth rate of 1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 273.02K | -9.38% |
| Dec 31, 2025 | 301.28K | 30.86% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 584.59K |
| Regenerative Medical Technology Group | 512.42K |
| Altamira Therapeutics | 457.24K |
| Innovation Pharmaceuticals | 423.01K |
| Helix BioMedix | 402.23K |
| Actavia Life Sciences | 385.91K |
| THC Farmaceuticals | 326.37K |
| Sorrento Therapeutics | 271.86K |